IBCD Lobby - access virtual conference

Programme

Programme - Illustration

A panel of pathologists, clinical researchers, industry representatives, regulators and patient advocates will address burning topics such as critical issues in drug and biomarker development, comparative effectiveness research and the translation of findings of clinical trials into daily practice. The conference will also discuss and debate the emergence of new regulatory routes to approve new anti-cancer agents based on biomarkers, demonstrating the relevance and feasibility of innovative clinical trial designs.

Read more

Acknowledgments

We wish to thank our sponsors for their generous support.

Leading supporter

Daiichi-Sankyo - Logo

Leading supporter

Novartis - Logo

Leading supporter

Roche - Logo

Driver supporter

Janssen Oncology - Logo

Scientific Committee

Roberto Salgado - EORTC

Robert Salgado, Belgium
Chair

EORTC

Luc Dirix - EORTC

Luc Dirix, Belgium

Elisa Giovannetti - EORTC

Elisa Giovanetti, Italy

NCI

Tracy Lively - NCI

Tracy Lively, USA,
Cochair

Sherry X. Yang - NCI

Sherry Yang, USA

EMA

Paolo Foggi, Italy
Cochair

Jonas Bergh - EMA

Jonas Bergh, Sweden

AACR

David Solit - AACR

David Solit, USA,
Cochair

Kurt Schalper - AACR

Kurt Schalper, USA